Invesco India Small Cap Fund Direct Growth NAV Advances to ₹54.76 on 23 September; 3-Year CAGR at 24.07%

Key Takeaways:

• Invesco India Small Cap Fund Direct Growth recorded an NAV of ₹54.76 on 23 September 2026, an increase of 0.77% from the preceding valuation. 
• The fund returned 16.91% over the latest year, while the three-year CAGR was higher at 24.07% and the five-year CAGR stood at 20.36%. 
• The three-year annualised return exceeded the five-year CAGR by 3.71 percentage points and the latest one-year return by 7.16 percentage points. 
• Net current assets represented 5.14% in the cited portfolio snapshot, while Sai Life Sciences was the largest listed equity holding among those entries at 4.94%. The five cited entries together accounted for 22.71%. 

Invesco India Small Cap Fund Direct Growth advanced 0.77% to ₹54.76 on 23 September 2026. Historical returns were positive across the three standard periods available: the latest one-year return stood at 16.91%, the three-year CAGR at 24.07%, and the five-year CAGR at 20.36%. 

The three-year annualised return was the highest of those three figures. It exceeded the five-year CAGR by 3.71 percentage points and the one-year return by 7.16 percentage points. Each result belongs to a different historical interval, so the comparison describes variation across periods rather than a single trend rate. 

The scheme managed approximately ₹15,744 crore, with a Direct Growth expense ratio of 0.63%. The minimum SIP and minimum lump-sum investment were each listed at ₹100. 

Recent portfolio data showed net current assets at 5.14%, Sai Life Sciences at 4.94%, Eternal at 4.62%, Krishna Institute of Medical Sciences at 4.10% and Aditya Infotech at 3.91%. Those five disclosed entries together represented 22.71%. Since net current assets are not an equity holding, Sai Life Sciences was the largest listed equity position among the cited entries. 

The 23 September NAV move was below 1% but comfortably positive. That one-day change sits alongside a return profile in which the three-year CAGR remained above both the one- and five-year figures. Portfolio weights, AUM and costs offer additional context, but none of these historical measures determines how the next NAV will behave. 

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.